Skip to main
INSP

INSP Stock Forecast & Price Target

INSP Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 12%
Buy 35%
Hold 53%
Sell 0%
Strong Sell 0%

Bulls say

Inspire Medical Systems is experiencing growth and success due to its dominant position in the minimally invasive solutions market for patients with obstructive sleep apnea (OSA). With a strong presence in the United States and other countries, the company generates the majority of its revenue from its flagship product, the Inspire system. While there are potential risks such as changes in reimbursement/coding and competition from other neurostimulation products, the company's overall growth prospects and forecasted earnings demonstrate its potential for continued success.

Bears say

Inspire Medical Systems is facing several headwinds that could potentially impact its financial performance. These headwinds include lower reimbursement rates for its Inspire system procedures, uncertainty around coding and pricing of its products, potential competition from other devices and therapies, and delays in obtaining a new CPT code that could support reimbursement for its newer device, the Genio implant. These factors could lead to lower revenue growth and margin compression for the company in the near term, and it may struggle to achieve double-digit revenue growth without addressing these challenges in a timely manner. Overall, we believe that the uncertainties surrounding reimbursement and coding for the company's products make its stock a risky investment at this time, and we have a negative outlook on its future financial performance.

INSP has been analyzed by 17 analysts, with a consensus rating of Buy. 12% of analysts recommend a Strong Buy, 35% recommend Buy, 53% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Inspire Medical Systems Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Inspire Medical Systems Inc (INSP) Forecast

Analysts have given INSP a Buy based on their latest research and market trends.

According to 17 analysts, INSP has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $97.94, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $97.94, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Inspire Medical Systems Inc (INSP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.